RHONE POULENC RORER INC
SC 13D/A, 1994-06-09
PHARMACEUTICAL PREPARATIONS
Previous: PRICE T ROWE TAX FREE INCOME FUND INC, 485APOS, 1994-06-09
Next: FIDELITY CAPITAL TRUST, N-30B-2, 1994-06-09



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549


                                  SCHEDULE 13D
                   Under the Securities Exchange Act of 1934

                               (Amendment No. 6)

                           RHONE-POULENC RORER INC.
                     ------------------------------------
                               (Name of issuer)

                       Common Shares, without par value
                       --------------------------------
                         (Title of class of securities)


                                  76242T 10 4
                            ----------------------
                                 (CUSIP Number)


                                  Yves Brissy
                               Rhone-Poulenc S.A.
                              25 Quai Paul Doumer
                         92408 Courbevoie Cedex, France
                               (331) 47-68-12-34
              -------------------------------------------------
                (Name, address, and telephone number of person
               authorized to receive notices and communications)


                    Copies of all notices should be sent to:

                          Hubertus V. Sulkowski Esq.
                              Shearman & Sterling
                                12, rue d'Astorg
                              75008 Paris, France
                               (331) 44-71-17-17


                                  June 8, 1994
                    --------------------------------------
                         (Date of event which requires
                           filing of this statement)


         If the filing person has previously filed a statement
on Schedule 13G to report the acquisition which is the subject
of this statement, and is filing this statement because of Rule
13d-1(b) (3) or (4), check the following box:  / /

Check the following box if a fee is being paid with this
statement:  / /
<PAGE>   2
CUSIP No. 76242T 10 4

(1)  Name of Reporting Person
     S.S. or I.R.S. Identification No. of Above Person

     Rhone-Poulenc S.A.

(2)  Check the Appropriate Box if a Member of a Group (See
     Instructions)

/ /  (a)

/ /  (b)


(3)  SEC Use Only


(4)  Source of Funds (See Instructions)


(5)  Check if Disclosure of Legal Proceedings is Required
     Pursuant to Item 2(d) or 2(e).
                                                         / /

(6)  Citizenship or Place of Organization  France



 Number of       (7) Sole Voting Power                  94,987,762
 Shares
Beneficially     (8) Shared Voting Power
 Owned by
   Each          (9) Sole Dispositive Power             94,987,762
Reporting
  Person        (10) Shared Dispositive Power
   With

(11) Aggregate Amount Beneficially Owned by Each Reporting
      Person                                            94,987,762


(12) Check if the Aggregate Amount in Row (11) Excludes
     Certain Shares (See Instructions)
                                                            / /

(13) Percent of Class Represented by Amount in Row (11)
     Approximately 68.3 % (based upon 138,986,185 shares outstanding as of
     March 10, 1994 (including 2,693,700 shares in RPR's Employee Benefits
     Trust), according to Rhone-Poulenc Rorer Inc.'s Proxy Statement dated
     March 21, 1994).

(14) Type of Reporting Person (See Instructions)  CO
<PAGE>   3
         This Amendment No. 6 amends the Statement on Schedule 13D (the
"Statement on Schedule 13D") filed by Rhone-Poulenc S.A., a French societe
anonyme ("RPSA"), with the Securities and Exchange Commission and is filed to
reflect information required pursuant to Rule 13d-2 of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended, relating to
shares of common stock, without par value, of Rhone-Poulenc Rorer Inc., a
Pennsylvania corporation ("RPR" or the "Issuer"). Unless otherwise defined
herein, all capitalized terms shall have the meanings ascribed thereto in the
Statement on Schedule 13D.

Item 4.  Purpose of Transaction.

         Item 4 of the Statement on Schedule 13D is hereby amended by adding
the following:

         In connection with RPSA's previously disclosed consideration of
     alternative transactions involving RPR, on June 8, 1994, RPSA received a
     letter (the "Letter") signed by all of the Independent Directors of RPR
     pursuant to which RPSA agreed that in pursuing any acquisition and
     investment opportunities that would involve combinations of businesses
     with those of RPR, RPSA would engage in certain consultations with RPR
     management. A copy of the Letter has been filed as an exhibit hereto and
     is incorporated by reference herein. The above summary of the Letter is
     qualified in its entirety by reference to the Letter.


Item 6.  Contracts, Arrangements, Understandings, or 
         Relationships with Respect to Securities of the
         Issuer

         Item 6 of the Statement on Schedule 13D is hereby amended by adding
the following:

     Letter Agreement

         Reference is made to the Letter summarized in Item 4 and filed as an
     exhibit hereto and incorporated by reference herein.

<PAGE>   4
        Item 7.         Material to be Filed as Exhibits.

             Item 7 of the Statement on Schedule 13D is hereby 
amended by adding the following exhibit:

Exhibit                         Description
  No.

    5.           Letter, dated as of June 2, 1994,
                 from Rhone-Poulenc S.A. to the 
                 Independent Directors of Rhone-Poulenc 
                 Rorer Inc.
<PAGE>   5
                                      12
                                      
                                  SIGNATURE


              After reasonable inquiry and to the best of my knowledge and 
belief, I certify that the information set forth in this statement is true,
complete and correct.

                                      RHONE-POULENC S.A.



                                      By /s/ Jean-Pierre Tirouflet
                                         -----------------------------------
                                         Name:  Jean-Pierre Tirouflet
                                         Title: Executive Group Vice President




Dated:  June 9, 1994
<PAGE>   6
                                Exhibit Index

Exhibit
  No.                           Description                        
- --------                        -----------                        

    5.                  Letter, dated as of June 2, 1994,              
                        from Rhone-Poulenc S.A. to the 
                        Independent Directors of Rhone-Poulenc 
                        Rorer Inc.

<PAGE>   1
                                                                       Exhibit 5
                                                                       ---------


                              Copy to other directors of RHONE-POULENC RORER INC
RHONE-POULENC S.A.

25 QUAI PAUL DOUMER
92408 COURBEVOIE CEDEX
TEL. (1) 47 58 12 34
TLX 610500 F RHONE


    Mr. Michael H. JORDAN
    Mr. James S. RIEPE
    Edward J. STEMMLER M.D.
    "As Independent Directors of"

    RHONE-POULENC RORER INC.
    500 Arcola Road
    COLLEGEVILLE, PA  19426 (USA)



    Gentlemen,

    As you are aware, RHONE-POULENC SA reviews acquisition and investment
    opportunities in its core business markets on a continuing basis and
    certain of such opportunities may involve combinations of businesses
    which may be complementary with those of RHONE-POULENC RORER INC
    ("RPR").  We want to assure you that before any proposal is made to an
    acquisition candidate during the Standstill Period (as defined in the
    Acquisition Agreement referred to below) where a combination with RPR
    would be involved, we would seek the views of RPR management on the
    merits of the acquisition as it relates to RPR's business and operations.
    In addition, we will keep RPR management advised of the status of the
    discussions and negotiations with any such acquisition candidate, and
    prior to making any definitive proposal which would involve RPR, we will
    consult with RPR management and obtain their approval of the terms of
    any such proposal.  Should the discussions with such an acquisition
    candidate proceed to the point of negotiating an acquisition agreement,
    the Independent Directors (as defined in the Acquisition Agreement, dated
    as of March 12, 1990 between RHONE-POULENC SA and RORER GROUP INC) of RPR
    would have the opportunity to review and approve the proposed terms of
    such acquisition as they relate to RPR and the terms of any proposed
    combination with RPR.  In addition, no public announcements involving
    such business combination with RPR would be made by RP without first
    consulting RPR management.

    Please confirm that you are in accord with the foregoing by signing in the
    space provided below.

                                              Very truly yours,


    Agreed to and acknowledged as of the
    2nd day of June, 1994

    /s/ Michael H. JORDAN                     /s/ Jean-Rene FOURTOU
    ----------------------                    ----------------------
    Michael H. JORDAN                         Jean-Rene FOURTOU
                                              Chairman
    /s/ James S. RIEPE
    -------------------
    James S. RIEPE

    /s/ Edward J. STEMMLER M.D.
    ----------------------------
    Edward J. STEMMLER M.D.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission